A
Antonio Artigas
Researcher at Autonomous University of Barcelona
Publications - 348
Citations - 32700
Antonio Artigas is an academic researcher from Autonomous University of Barcelona. The author has contributed to research in topics: Intensive care & Medicine. The author has an hindex of 65, co-authored 297 publications receiving 28659 citations. Previous affiliations of Antonio Artigas include University of Toronto & University of Barcelona.
Papers
More filters
Journal ArticleDOI
The American-European Consensus Conference on ARDS: Definitions, mechanisms, relevant outcomes, and clinical trial coordination
Gordon R. Bernard,Antonio Artigas,Kenneth L. Brigham,J. Carlet,K. Falke,L. Hudson,M. Lamy,J. R. LeGall,Alan H. Morris,Roger G. Spragg +9 more
TL;DR: The acute respiratory distress syndrome (ARDS), a process of nonhydrostatic pulmonary edema and hypoxemia associated with a variety of etiologies, carries a high morbidity, mortality, and financial cost.
Journal ArticleDOI
The Surviving Sepsis Campaign: results of an international guideline-based performance improvement program targeting severe sepsis
Mitchell M. Levy,R. Phillip Dellinger,Sean R. Townsend,Walter T. Linde-Zwirble,John C. Marshall,Julian Bion,Christa A. Schorr,Antonio Artigas,Graham Ramsay,Richard Beale,Margaret M. Parker,Herwig Gerlach,Konrad Reinhart,Eliezer Silva,Maurene A. Harvey,Susan Regan,Derek C. Angus +16 more
TL;DR: The Surviving Sepsis Campaign was associated with sustained, continuous quality improvement in sepsis care and a reduction in reported hospital mortality rates wasassociated with participation.
Journal ArticleDOI
Empiric Antibiotic Treatment Reduces Mortality in Severe Sepsis and Septic Shock From the First Hour: Results From a Guideline-Based Performance Improvement Program*
Ricard Ferrer,Ignacio Martin-Loeches,Gary Phillips,Tiffany M. Osborn,Sean R. Townsend,R. Phillip Dellinger,Antonio Artigas,Christa Schorr,Mitchell M. Levy +8 more
TL;DR: The results of the analysis of this large population of patients with severe sepsis and septic shock demonstrate that delay in first antibiotic administration was associated with increased in-hospital mortality, and there was a linear increase in the risk of mortality for each hour delay in antibiotic administration.
Journal ArticleDOI
Drotrecogin alfa (activated) in adults with septic shock
V. Marco Ranieri,B. Taylor Thompson,Philip S. Barie,Jean-François Dhainaut,Ivor S. Douglas,Simon Finfer,Simon Finfer,Bengt Gårdlund,John C. Marshall,Andrew Rhodes,Antonio Artigas,Didier Payen,Jyrki Tenhunen,Hussein R. Al-Khalidi,Vivian P. Thompson,Jonathan Janes,William L. Macias,Burkhard Vangerow,Mark D. Williams +18 more
TL;DR: DrotAA did not significantly reduce mortality at 28 or 90 days, as compared with placebo, in patients with septic shock, and rates of death at 28 and 90 days were not significantly different in other predefined subgroups, including patients at increased risk for death.
Journal ArticleDOI
Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury.
Kianoush Kashani,Ali Al-Khafaji,Thomas Ardiles,Antonio Artigas,Sean M. Bagshaw,Max Bell,Azra Bihorac,Robert H. Birkhahn,Cynthia M. Cely,Lakhmir S. Chawla,Danielle Davison,Thorsten Feldkamp,Lui G. Forni,Michelle N. Gong,Kyle J. Gunnerson,Michael Haase,James Hackett,Patrick M. Honore,Eric Hoste,Olivier Joannes-Boyau,Michael Joannidis,Patrick K. Kim,Jay L. Koyner,Daniel T. Laskowitz,Matthew Lissauer,Gernot Marx,Peter A. McCullough,Scott Mullaney,Marlies Ostermann,Thomas Rimmelé,Nathan I. Shapiro,Andrew D. Shaw,Jing Shi,Amy M Sprague,Jean Louis Vincent,Christophe Vinsonneau,Ludwig Wagner,Michael G. Walker,R. Gentry Wilkerson,Kai Zacharowski,John A. Kellum +40 more
TL;DR: Two novel markers for AKI have been identified and validated in independent multicenter cohorts and are superior to existing markers, provide additional information over clinical variables and add mechanistic insight into AKI.